|
|
|
|
| LEADER |
01746nam a2200325 u 4500 |
| 001 |
EB001839372 |
| 003 |
EBX01000000000000001003361 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 100 |
1 |
|
|a Edge, Rob
|
| 245 |
0 |
0 |
|a Self-monitoring of blood glucose frequency for patients with hypoglycemia unawareness
|h Elektronische Ressource
|b a review of clinical effectiveness and guidelines
|c Rob Edge, Melissa Severn
|
| 246 |
3 |
1 |
|a SMBG frequency for patients with hypoglycemia unawareness
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2017, April 5, 2017
|
| 300 |
|
|
|a 1 PDF file (7 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Blood Glucose Self-Monitoring
|
| 653 |
|
|
|a Diabetes Mellitus, Type 1 / diagnosis
|
| 653 |
|
|
|a Guidelines as Topic
|
| 653 |
|
|
|a Hypoglycemia / blood
|
| 700 |
1 |
|
|a Severn, Melissa
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH apid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK470746
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to retrieve and review the existing clinical effectiveness evidence for various frequencies of SMBG with test strips for patients with type 1 DM and hypoglycemia unawareness. Additionally, this report aims to retrieve and review evidence-based guidelines regarding the optimal frequency of SMBG with test strips for this patient population
|